Ultragenyx Pharmaceutical | RARE - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Acadia Pharmaceuticals USD 1.31B 58.54M 2026-06
Agios Pharmaceuticals USD 1.03B 83.09M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
BioCryst Pharmaceuticals USD -553.84M 434.69M 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Immunic USD 151.23M 157.91M 2026-03
Insmed USD 704.85M 34.12M 2026-03
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
Karyopharm Therapeutics USD -265.65M 27.28M 2026-03
Kyowa Hakko Kirin JPY 916.17B 23.42B 2026-06
MacroGenics USD 21.2M 34.39M 2026-03
Moderna USD 6.76B 647M 2026-06
Neurocrine Biosciences USD 3.69B 286.2M 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Ultragenyx Pharmaceutical USD -291M 55M 2026-06
Vertex Pharmaceuticals USD 20.25B 886M 2026-06